Atipamezole hydroChloride - CAS 104075-48-1
Catalog number:
104075-48-1
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H16N2.HCl
Molecular Weight:
248.75
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
The hydrochloride salt form of atipamezole that is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>99 %
Appearance:
White Solid
Synonyms:
1H-Imidazole, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-, monohydrochloride;Atipamezole HCL;4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole hydrochloride;4-(2-Ethyl-2-indanyl)imidazole hydrochloride;Atipamezole hydrochloride;Unii-2W4279571x
Solubility:
DMSO > 47mg/ml
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
The hydrochloride salt form of atipamezole that is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
367.1ºC at 760mmHg
Melting Point:
216-219°C
Density:
1.115g/cm3
InChIKey:
PCCVCJAQMHDWJY-UHFFFAOYSA-N
InChI:
1S/C14H16N2.ClH/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14;/h3-6,9-10H,2,7-8H2,1H3,(H,15,16);1H
Canonical SMILES:
CCC1(C2=CN=CN2)CC3=CC=CC=C3C1.Cl
1.Anesthetic and cardiopulmonary effects of intramuscular morphine, medetomidine, ketamine injection in dogs.
Ueyama Y1, Waselau AC, Wiese AJ, Muir WW. Vet Anaesth Analg. 2008 Nov;35(6):480-7. doi: 10.1111/j.1467-2995.2008.00415.x. Epub 2008 Aug 15.
OBJECTIVE: To determine the quality and duration of anesthesia and the cardiopulmonary effects of a morphine, medetomidine, ketamine (MMK) combination administered intramuscularly (IM) to dogs.
2.Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
Finnema SJ1, Hughes ZA2, Haaparanta-Solin M2, Stepanov V2, Nakao R2, Varnäs K2, Varrone A2, Arponen E2, Marjamäki P2, Pohjanoksa K2, Vuorilehto L2, Babalola PA2, Solin O2, Grimwood S2, Sallinen J2, Farde L2, Scheinin M2, Halldin C2. Int J Neuropsychopharmacol. 2014 Dec 13;18(3). pii: pyu081. doi: 10.1093/ijnp/pyu081.
BACKGROUND: The neurotransmitter norepinephrine has been implicated in psychiatric and neurodegenerative disorders. Examination of synaptic norepinephrine concentrations in the living brain may be possible with positron emission tomography (PET), but has been hampered by the lack of suitable radioligands.
3.Effects of alpha-adrenergic agonists on pain modulation in diffuse noxious inhibitory control.
Sanada T1, Kohase H, Makino K, Umino M. J Med Dent Sci. 2009 Mar;56(1):17-24.
BACKGROUND: Diffuse noxious inhibitory control (DNIC) is thought to be mediated by neural networks in supraspinal brain structures. The descending antinociceptive system (DAS) is an important component of the DNIC neural network, but the precise structure of the neural network and the related neurotransmitters have not been examined.
4.Effects of a medetomidine-ketamine combination on Schirmer tear test I results of clinically normal cats.
Di Pietro S, Macrì F, Bonarrigo T, Giudice E, Palumbo Piccionello A, Pugliese A. Am J Vet Res. 2016 Mar;77(3):310-4. doi: 10.2460/ajvr.77.3.310.
OBJECTIVE To evaluate the effects of a medetomidine-ketamine combination on tear production of clinically normal cats by use of the Schirmer tear test (STT) 1 before and during anesthesia and after reversal of medetomidine with atipamezole. ANIMALS 40 client-owned crossbred domestic shorthair cats (23 males and 17 females; age range, 6 to 24 months). PROCEDURES A complete physical examination, CBC, and ophthalmic examination were performed on each cat. Cats with no abnormalities on physical and ophthalmic examinations were included in the study. Cats were allocated into 2 groups: a control group (n = 10 cats) anesthetized by administration of a combination of medetomidine hydrochloride (80 μg/kg) and ketamine hydrochloride (5 mg/kg), and an experimental group (30) anesthetized with the medetomidine-ketamine combination and reversal by administration of atipamezole. Tear production of both eyes of each cat was measured by use of the STT I before anesthesia, 15 minutes after the beginning of anesthesia, and 15 minutes after administration of atipamezole.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 57262-94-9 Setiptiline

Setiptiline
(CAS: 57262-94-9)

Setiptiline is is a serotonin receptor antagonist acts as a noradrenergic and specific serotonergic antidepressant.

CAS 74191-85-8 Doxazosin

Doxazosin
(CAS: 74191-85-8)

Doxazosin is a quinazoline-derivative and long-lasting α1 adrenergic receptor blocker. It inhibits the binding of norepinephrine, which is released from sympath...

CAS 54-80-8 Pronetalol

Pronetalol
(CAS: 54-80-8)

Pronethalol is a non-selective beta-adrenergic blocking agentused in treatment due to carcinogenic properties.

CAS 586-06-1 Orciprenaline

Orciprenaline
(CAS: 586-06-1)

Orciprenaline is a moderately selective beta-adrenergic agonist used in the treatment of asthma and bronchospasms. It stimulates receptors of the smooth muscle ...

CAS 23256-50-0 Guanabenz Acetate

Guanabenz Acetate
(CAS: 23256-50-0)

Guanabenz Acetate is an selective agonist of α2a-adrenergic receptor, α2b-adrenergic receptor and α2c-adrenergic receptor with pEC50 of 8.25, 7.01 and ~5, respe...

CAS 214548-46-6 Lusaperidone

Lusaperidone
(CAS: 214548-46-6)

Lusaperidone, also known as R107474, is an α2 adrenergic receptor antagonist. R107474 showed high affinity for ha2A-, ha2B-, and ha2C-adrenoceptors, stably expr...

CAS 29110-47-2 Guanfacine

Guanfacine
(CAS: 29110-47-2)

Guanfacine, a selective agonist of α2A receptor, is a sympatholytic drug to treat attention deficit hyperactivity disorder (ADHD) and hypertension. It lowers bo...

CAS 753498-25-8 Indacaterol Maleate

Indacaterol Maleate
(CAS: 753498-25-8)

Indacaterol is an ultra-long-acting β-adrenoceptor agonist with pKi of 7.36.

CAS 312753-06-3 Indacaterol

Indacaterol
(CAS: 312753-06-3)

Indacaterol Maleate is an ultra-long-acting β-adrenoceptor agonist.

CAS 22664-55-7 Metipranolol

Metipranolol
(CAS: 22664-55-7)

Metipranolol is a non-selective beta blocker used in eye drops to treat glaucoma.

CAS 34381-68-5 Acebutolol hydrochloride

Acebutolol hydrochloride
(CAS: 34381-68-5)

Acebutolol is a β-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias.

CAS 149247-12-1 QF0301B

QF0301B
(CAS: 149247-12-1)

QF0301B is an α1 adrenergic receptor antagonist and shows noncompetitive low action in 5-HT3, muscarinic and nicotinic receptors, or as Ca2+ antagonist.

CAS 13655-52-2 Alprenolol

Alprenolol
(CAS: 13655-52-2)

Alprenolol is a non-selective Beta-Adrenergic receptor and 5-HT1A receptor antagonist for the treatment of angina pectoris.

CAS 804518-03-4 Milveterol hydrochloride

Milveterol hydrochloride
(CAS: 804518-03-4)

Milveterol is a long-acting β(2)-adrenoceptor agonist under the development of GlaxoSmithKline. Phase II trials for the treatment of Chronic obstructive pulmona...

CP-331684
(CAS: 207922-70-1)

CP-331684 is a β3-adrenergic receptor agonist used as antidiabetic drug.

Guanfacine Hydrochloride
(CAS: 249-443-3)

Guanfacine Hydrochloride is a centrally acting alpha-2 adrenergic agonist that has been available as an FDA-approved hypotensive agent for more than two decades...

CAS 51022-70-9 Salbutamol Sulfate

Salbutamol Sulfate
(CAS: 51022-70-9)

Salbutamol Sulfate is a Non-selective 2-adrenergic receptor agonist (IC50=8.93 µM)

CHIR 2279
(CAS: 158198-45-9)

CHIR 2279, an isoquinolin derivative, was once studied against hypertension as an α1 adrenergic receptor antagonist.

CAS 13523-86-9 Pindolol

Pindolol
(CAS: 13523-86-9)

Pindolol, an Indole derivative, could be used in the treatment of hypertension and arrhythmia for acting as a 5-HT1A/1B receptor antagonist. IC50: 33nM(Ki).

CAS 208992-74-9 Fiduxosin hydrochloride

Fiduxosin hydrochloride
(CAS: 208992-74-9)

Fiduxosin hydrochloride is an alpha(1)-adrenoceptor antagonist used for the treatment of benign prostatic hyperplasia.

Chemical Structure

CAS 104075-48-1 Atipamezole hydroChloride

Quick Inquiry

Verification code

Featured Items